CN113499354A - Eye lotion - Google Patents
Eye lotion Download PDFInfo
- Publication number
- CN113499354A CN113499354A CN202110982290.4A CN202110982290A CN113499354A CN 113499354 A CN113499354 A CN 113499354A CN 202110982290 A CN202110982290 A CN 202110982290A CN 113499354 A CN113499354 A CN 113499354A
- Authority
- CN
- China
- Prior art keywords
- eye
- taurine
- trehalose
- lotion
- eye lotion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses an eye lotion which is prepared from the following raw materials in parts by weight: 10-25% of chamomile hydrosol, 5-10% of trehalose, 5-10% of taurine, 610-30% of vitamin B, 5-15% of propylene glycol and 10-65% of purified water. The invention has the effects of cooling and refreshing eyes, relieving eye fatigue and eye itching, keeping eyes moist and repairing cornea.
Description
Technical Field
The invention relates to the technical field of eye lotion, and particularly relates to a chamomile pure dew eye lotion.
Background
The eye lotion is a popular product, and has a wider application range than common instruments and medicines. The eye lotion is added with pure natural active substances, is prepared into solution which is adaptive to human bodies by purified water or distilled water and inorganic salt substances, has good effects of cleaning and maintaining eyes, relieving eye fatigue, maintaining eye cleanness, slowing down some eye diseases, repairing some slight physical loss in the eyes and the like, can stimulate the circulation of ocular capillaries, meets the requirement of eye skin on nutrients, improves the problem of dark circles caused by tiredness, night stay, poor sleep and the like, and is very popular with consumers.
The existing eye lotion or eye drops with the functions of diminishing inflammation, resisting allergy or vasoconstriction and the like usually adopt drugs such as antibiotics and the like, have strong side effects, cause the problem of discomfort to normal people and have strong irritation to eyeballs. Therefore, there is a need for an eye lotion which is refreshing and striking, relieves eye fatigue, relieves eye itching, keeps eyes moist and repairs cornea.
Disclosure of Invention
The invention aims to provide an eye lotion which adopts chamomile hydrolat as a preparation raw material and has various effects of cooling, refreshing, striking eyes, relieving eye fatigue, relieving eye itching, keeping eyes moist and repairing cornea.
In order to solve the technical problems, the invention adopts the following technical scheme:
the invention provides an eye lotion which is characterized by being prepared from the following raw materials in parts by weight: 10-25% of chamomile hydrosol, 5-10% of trehalose, 5-10% of taurine, 610-30% of vitamin B, 5-15% of propylene glycol and 10-65% of purified water.
The invention has the beneficial effects that: the chamomile hydrosol is used as a preparation raw material, and has various effects of cooling, refreshing, eye fatigue relieving, eye itching relieving, eye moistening maintaining and cornea repairing.
The following further explains the beneficial effects of the present invention in combination with the efficacy of the main ingredients in the present invention:
blue chamomile hydrosol: has obvious auxiliary treatment effect on eye fatigue, eye red swelling, eye dark circles and eye trauma, and is an important substance for eye care. In addition, eye fatigue, swelling and itching caused by air pollution or sitting in front of a computer for a long time can be treated by using the chamomile hydrosol.
Trehalose: trehalose can effectively reduce the death rate of corneal epithelial cells in a dry environment and treat xerophthalmia.
Trehalose has a magical protective effect on organisms because trehalose can form a unique protective film on the cell surface under severe environmental conditions such as high temperature, high cold, high osmotic pressure, drying and dehydration and the like, so that protein molecules are effectively protected from being inactivated without denaturation, and the life process and biological characteristics of the organisms are maintained. The special small molecules can permeate into cells, keep the activity of the cells, lock water and preserve moisture.
Taurine: taurine is also present in large amounts in the retina of the human eye and therefore supplementation with taurine is also of major importance for the human eye. Exogenous taurine can smoothly pass through a crystal cell membrane without a carrier and consuming energy, and the nutritional function of the taurine is very important for maintaining the metabolism of eyes, and is mainly used for preventing and treating myopia and resisting asthenopia clinically. Enhance cell metabolism and promote ocular tissue repair caused by inflammatory injury.
Vitamin B6: can improve local nerve function, relieve inflammation, supply nutrition to eye, supplement vitamins required by eye, maintain eye nervous system health, resist oxidation, prevent eye diseases, and keep eye bright and clear.
Detailed Description
The technical solutions of the present invention will be described clearly and completely in the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The eye lotion is prepared from the following raw materials in parts by weight: 15% of chamomile hydrosol, 10% of trehalose, 5% of taurine, 630% of vitamin B, 5% of propylene glycol and 35% of purified water.
Example 2
The eye lotion is prepared from the following raw materials in parts by weight: 20% of chamomile hydrosol, 10% of trehalose, 5% of taurine, 615% of vitamin B, 10% of propylene glycol and 40% of purified water.
Example 3
The eye lotion is prepared from the following raw materials in parts by weight: 25% of chamomile hydrosol, 5% of trehalose, 5% of taurine, 620% of vitamin B, 10% of propylene glycol and 35% of purified water.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.
Claims (1)
1. The eye lotion is characterized by being prepared from the following raw materials in parts by weight: 10-25% of chamomile hydrosol, 5-10% of trehalose, 5-10% of taurine, 610-30% of vitamin B, 5-15% of propylene glycol and 10-65% of purified water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110982290.4A CN113499354A (en) | 2021-08-25 | 2021-08-25 | Eye lotion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110982290.4A CN113499354A (en) | 2021-08-25 | 2021-08-25 | Eye lotion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113499354A true CN113499354A (en) | 2021-10-15 |
Family
ID=78016150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110982290.4A Pending CN113499354A (en) | 2021-08-25 | 2021-08-25 | Eye lotion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113499354A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114177280A (en) * | 2021-12-17 | 2022-03-15 | 上海卫康光学眼镜有限公司 | Eye lotion containing stable antioxidant enzyme and preparation method thereof |
| CN117243869A (en) * | 2023-11-13 | 2023-12-19 | 宝萃生物科技有限公司 | Blue chamomile pure dew and preparation and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107362128A (en) * | 2017-08-08 | 2017-11-21 | 广州蜜妆生物科技有限公司 | A kind of blue camomile quintessence repairs facial mask |
| CN109908199A (en) * | 2019-04-24 | 2019-06-21 | 嘉兴力山明朗生物医药科技有限公司 | A kind of chamomile collyrium |
-
2021
- 2021-08-25 CN CN202110982290.4A patent/CN113499354A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107362128A (en) * | 2017-08-08 | 2017-11-21 | 广州蜜妆生物科技有限公司 | A kind of blue camomile quintessence repairs facial mask |
| CN109908199A (en) * | 2019-04-24 | 2019-06-21 | 嘉兴力山明朗生物医药科技有限公司 | A kind of chamomile collyrium |
Non-Patent Citations (2)
| Title |
|---|
| 无: "德国蓝甘菊纯露 （有机）功效及使用", 《HTTPS://WWW.NMYYC.COM/ARTICLE/DETAIL-84/NAVID/21.HTML》 * |
| 高洪瑞等: "海藻糖及其在眼科的研究进展", 《国际眼科杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114177280A (en) * | 2021-12-17 | 2022-03-15 | 上海卫康光学眼镜有限公司 | Eye lotion containing stable antioxidant enzyme and preparation method thereof |
| CN117243869A (en) * | 2023-11-13 | 2023-12-19 | 宝萃生物科技有限公司 | Blue chamomile pure dew and preparation and application thereof |
| CN117243869B (en) * | 2023-11-13 | 2024-02-02 | 宝萃生物科技有限公司 | Blue chamomile pure dew and preparation and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bergman et al. | Acceleration of wound healing by topical application of honey: an animal model | |
| CN113499354A (en) | Eye lotion | |
| CN104644523B (en) | A kind of medical bio smoothing wrinkle suppression spot dressing and preparation method thereof | |
| CN104921983A (en) | Medical biological repairing dressing for pregnant woman striae gravidarum and preparation method thereof | |
| CN110051602B (en) | Skin moistening, moisturizing and repairing emulsion and preparation method thereof | |
| CN107303253A (en) | It is a kind of to be used to be damaged renovation agent of skin and preparation method thereof | |
| CN109908198A (en) | A kind of corn flower collyrium | |
| CN106617102A (en) | Collagen nutrient power and preparation method thereof | |
| CN108815100A (en) | Bacterio static itching-relieving skin care item and preparation method thereof containing folium artemisiae argyi stem cell extract | |
| CN112842943A (en) | Itching-relieving moisturizing skin-repairing cream and preparation method thereof | |
| CN100376233C (en) | Food and medicine dual purpose product for preventing and treating vision injury syndrome duo to TV and computer display light and its manufacturing method | |
| CN1823822A (en) | Food and medicien nutritive element for preventing and treating vision syndrome due to computer and its manufacturing method | |
| CN1823821A (en) | Vitamin and microelements nutritive product for preventing and treating vision syndrome due to computer and its manufacturing method | |
| CN112076128A (en) | Anti-aging repairing day cream and preparation method thereof | |
| CN108078868B (en) | Antiallergic composition for skin care products | |
| CN113925828A (en) | Borneol eye lotion | |
| CN104288020A (en) | Multifunctional edible mask powder and preparation method thereof | |
| CN107551090A (en) | One kind, which is nourished, repairs gel | |
| KR102342731B1 (en) | Composition For Eyelid or Periocular Region Washing and Pad Comprising Thesame | |
| CN113786371A (en) | Composition for preparing blueberry seaweed mask, mask and preparation method | |
| CN111110817A (en) | Traditional Chinese medicine composition for treating eye diseases, preparation method and application thereof | |
| CN110585040A (en) | Plant bacteriostatic moisturizing mask and preparation process thereof | |
| CN110101585A (en) | A kind of netted staggeredly eye mask and preparation method thereof of 3D | |
| CN116139192B (en) | Visual nutrition supplement and preparation method and application thereof | |
| CN114533582B (en) | Periocular composition containing multiple osmoprotectants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211015 |
|
| RJ01 | Rejection of invention patent application after publication |